Tone mix
Week by week 52 weeks
Share of Krystal Biotech, Inc. Common Stock's 148 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Aug 25, 2025 · tone -100Krystal Biotech halts cancer drug trial - Becker's Hospital Review-129
- Week of Jun 9, 2025 · tone +100Krystal Biotech, Inc. (KRYS): Investor Outlook on a Promising 49.85% Upside Potential+76
- Week of Jun 15, 2026 · tone +100Krystal Biotech, Inc. (NASDAQ:KRYS) Given Average Recommendation of "Moderate Buy" by Analysts+73
- Week of Aug 11, 2025 · tone +100Krystal Biotech, Inc. (KRYS) Stock Analysis: Unpacking The 48.20% Potential Upside In Genetic Medicine Innovations+68
- Week of Mar 2, 2026 · tone +100Guggenheim Lifts PT on Krystal Biotech (KRYS) to $284 From $224+65
- Week of Mar 30, 2026 · tone +99Krystal Biotech, Inc. (NASDAQ:KRYS) Receives $326.25 Average PT from Brokerages+65
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Krystal Biotech, Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 8 | +13 |
| Last 30 sessions | 16 | +25 |
| Last 90 sessions | 31 | +22 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Wednesday, November 4, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.dailypolitical.com · 1 outletKrystal Biotech, Inc. $KRYS Stock: Torray Investment Partners LLC Decreases PositionNeutral
- www.themarketsdaily.com · 1 outletKrystal Biotech (KRYS) and Its Peers Financial SurveyNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Krystal Biotech, Inc. $KRYS Stock: Torray Investment Partners LLC Decreases Position | www.dailypolitical.com | 1 | Neutral |
| Krystal Biotech (KRYS) and Its Peers Financial Survey | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, November 3, 2026
3 headlines, average tone +2: 1 positive, 1 neutral and 1 negative. Showing all 3.
- www.fool.com · 2 outletsKrystal Biotech (KRYS) Q3 2026 Earnings Call TranscriptNeutral
- seekingalpha.com · 1 outletKrystal outlines $400M share repurchase over 2 years as it revises 2026 non-GAAP opex to $155M-$165M (NASDAQ:KRYS)Positive
- www.themarketsdaily.com · 1 outletKrystal Biotech's Vyjuvek sales jump 30% but net income slips (NASDAQ: KRYS)Negative
Show the table · 3 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Krystal Biotech (KRYS) Q3 2026 Earnings Call Transcript | www.fool.com | 2 | Neutral |
| Krystal outlines $400M share repurchase over 2 years as it revises 2026 non-GAAP opex to $155M-$165M (NASDAQ:KRYS) | seekingalpha.com | 1 | Positive |
| Krystal Biotech's Vyjuvek sales jump 30% but net income slips (NASDAQ: KRYS) | www.themarketsdaily.com | 1 | Negative |
No matching rows. Clear the filter to see all records.
Headlines on Monday, November 2, 2026
3 headlines, average tone +33: 1 positive, 2 neutral and 0 negative. Showing all 3.
- www.dailypolitical.com · 1 outletKrystal Biotech (NASDAQ:KRYS) Releases Earnings Results, Beats Estimates By $0.26 EPSPositive
- www.manilatimes.net · 1 outletKrystal Biotech Announces Third Quarter 2026 Financial and Operating ResultsNeutral
- www.tickerreport.com · 1 outletKrystal Biotech (KRYS) Set to Post Quarterly Earnings on MondayNeutral
Show the table · 3 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Krystal Biotech (NASDAQ:KRYS) Releases Earnings Results, Beats Estimates By $0.26 EPS | www.dailypolitical.com | 1 | Positive |
| Krystal Biotech Announces Third Quarter 2026 Financial and Operating Results | www.manilatimes.net | 1 | Neutral |
| Krystal Biotech (KRYS) Set to Post Quarterly Earnings on Monday | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 21, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.tickerreport.com · 1 outletMonte Rosa Therapeutics (NASDAQ:GLUE) versus Krystal Biotech (NASDAQ:KRYS) Head to Head SurveyNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Monte Rosa Therapeutics (NASDAQ:GLUE) versus Krystal Biotech (NASDAQ:KRYS) Head to Head Survey | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 16, 2026
3 headlines, average tone +66: 2 positive, 1 neutral and 0 negative. Showing all 3.
- www.rttnews.com · 1 outletKrystal Biotech Sees Broad Antitumor Activity With KB113 In Gorlin Syndrome; Stock UpPositive
- www.rttnews.com · 1 outletKrystal Biotech Reports Over 80% Lesion Regression With KB113 In Gorlin SyndromePositive
- www.themarketsdaily.com · 1 outletComparing Krystal Biotech (NASDAQ:KRYS) and Applied Therapeutics (NASDAQ:APLT)Neutral
Show the table · 3 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Krystal Biotech Sees Broad Antitumor Activity With KB113 In Gorlin Syndrome; Stock Up | www.rttnews.com | 1 | Positive |
| Krystal Biotech Reports Over 80% Lesion Regression With KB113 In Gorlin Syndrome | www.rttnews.com | 1 | Positive |
| Comparing Krystal Biotech (NASDAQ:KRYS) and Applied Therapeutics (NASDAQ:APLT) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Krystal Biotech, Inc. Common Stock, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.